Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix

被引:12
作者
Gavenonis, Jason [1 ]
Jonas, Nicholas E. [1 ]
Kritzer, Joshua A. [1 ]
机构
[1] Tufts Univ, Dept Chem, Medford, MA 02155 USA
关键词
Peptides; Stapled helices; Protein-protein interactions; Hsp90; Molecular chaperones; HSP90; NOVOBIOCIN; DESIGN; SANSALVAMIDE; MODULATOR; ASSAY;
D O I
10.1016/j.bmc.2014.06.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hsp90 is a molecular chaperone implicated in many diseases including cancer and neurodegenerative disease. Most inhibitors target the ATPase site in Hsp9O's N-terminal domain, with relatively few inhibitors of other domains reported to date. Here, we show that peptides derived from a short helix at the C-terminus of Hsp90 show micromolar activity as Hsp90 inhibitors in vitro. These inhibitors do not block the N-terminal domain's ATP-binding site, and thus are likely to bind at the C-terminal domain. Substitutions and helix stapling were applied to demonstrate structure-activity relationships and improve activity. These helical peptides will help guide the design of a new class of inhibitors of Hsp9O's C-terminal domain. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3989 / 3993
页数:5
相关论文
共 34 条
[1]   Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex [J].
Ali, MMU ;
Roe, SM ;
Vaughan, CK ;
Meyer, P ;
Panaretou, B ;
Piper, PW ;
Prodromou, C ;
Pearl, LH .
NATURE, 2006, 440 (7087) :1013-1017
[2]   Heat Shock Protein 90: Inhibitors in Clinical Trials [J].
Biamonte, Marco A. ;
Van de Water, Ryan ;
Arndt, Joseph W. ;
Scannevin, Robert H. ;
Perret, Daniel ;
Lee, Wen-Cherng .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (01) :3-17
[3]  
Blackwell HE, 1998, ANGEW CHEM INT EDIT, V37, P3281, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3281::AID-ANIE3281>3.0.CO
[4]  
2-V
[5]   Getting in Shape: Controlling Peptide Bioactivity and Bioavailability Using Conformational Constraints [J].
Bock, Jonathan E. ;
Gavenonis, Jason ;
Kritzer, Joshua A. .
ACS CHEMICAL BIOLOGY, 2013, 8 (03) :488-499
[6]   Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines [J].
Burlison, Joseph A. ;
Avila, Christopher ;
Vielhauer, George ;
Lubbers, Donna J. ;
Holzbeierlein, Jeffrey ;
Blagg, Brian S. J. .
JOURNAL OF ORGANIC CHEMISTRY, 2008, 73 (06) :2130-2137
[7]   CYCLIC PARATHYROID-HORMONE RELATED PROTEIN ANTAGONISTS - LYSINE-13 TO ASPARTIC-ACID 17 [I TO (I + 4)] SIDE-CHAIN TO SIDE-CHAIN LACTAMIZATION [J].
CHOREV, M ;
ROUBINI, E ;
MCKEE, RL ;
GIBBONS, SW ;
GOLDMAN, ME ;
CAULFIELD, MP ;
ROSENBLATT, M .
BIOCHEMISTRY, 1991, 30 (24) :5968-5974
[8]   Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide-binding Pocket [J].
Donnelly, Alison ;
Blagg, Brian S. J. .
CURRENT MEDICINAL CHEMISTRY, 2008, 15 (26) :2702-2717
[9]   The Design, Synthesis, and Evaluation of Coumarin Ring Derivatives of the Novobiocin Scaffold that Exhibit Antiproliferative Activity [J].
Donnelly, Alison C. ;
Mays, Jared R. ;
Burlison, Joseph A. ;
Nelson, John T. ;
Vielhauer, George ;
Holzbeierlein, Jeffrey ;
Blagg, Brian S. J. .
JOURNAL OF ORGANIC CHEMISTRY, 2008, 73 (22) :8901-8920
[10]   High-throughput screening fluorescence polarization assay for tumor-specific Hsp90 [J].
Du, Yuhong ;
Moulick, Kamalika ;
Rodina, Anna ;
Aguirre, Julia ;
Felts, Sara ;
Dingledine, Raymond ;
Fu, Haian ;
Chiosis, Gabriela .
JOURNAL OF BIOMOLECULAR SCREENING, 2007, 12 (07) :915-924